Weber, J., Luke, J., Carlino, M., Khattak, M., Meehan, R., Brown, M., . . . Long, G. InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma. Elsevier.
Chicago Style (17th ed.) CitationWeber, J.S, et al. InterPATH-001 Trial in Progress: Adjuvant V940 (mRNA-4157) with Pembrolizumab Versus Placebo in Patients with High-risk Stage II-IV Melanoma. Elsevier.
MLA (9th ed.) CitationWeber, J.S, et al. InterPATH-001 Trial in Progress: Adjuvant V940 (mRNA-4157) with Pembrolizumab Versus Placebo in Patients with High-risk Stage II-IV Melanoma. Elsevier.
Warning: These citations may not always be 100% accurate.